Skip to content

APOTHEEK PUT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK PUT

BE 0884.692.260
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€8,200
2024 · €17,169-€8,969
Equity
€187,013
2024 · €178,813+€8,200
Cash
€108,749
2024 · €221,962-€113,213
Balance sheet total
€608,583
2024 · €598,046+€10,537

Largest movements

2024 to 2025
Assets
  • Cash -€113,213

    down €113,213 (-51.0%), from €221,962 to €108,749

    mainly Receivables within one year (-€83,382) and Stocks and contracts (-€36,123)

  • Receivables within one year +€83,382

    up €83,382 (+43.8%), from €190,228 to €273,610

    of which Other amounts receivable: +€53,047

  • Stocks and contracts +€36,123

    up €36,123 (+22.8%), from €158,559 to €194,683

  • Deferred charges and accrued income +€8,304

    up €8,304 (+45.5%), from €18,238 to €26,541

Equity and liabilities
  • Tax, wage and social debts +€16,181

    up €16,181 (+120.4%), from €13,436 to €29,617

    of which Remuneration and social security: +€12,535

  • Profit (loss) carried forward +€8,200

    up €8,200 (+5.5%), from €148,058 to €156,258

Income statement
  • Staff costs +€73,258

    up €73,258 (+56.0%), from €130,867 to €204,126

  • Gross operating margin +€66,762

    up €66,762 (+37.3%), from €179,178 to €245,940

  • Financial charges +€8,549

    up €8,549 (+52.6%), from €16,264 to €24,813

    of which Financial charges: +€8,548

  • Other operating charges -€2,969

    down €2,969 (-68.0%), from €4,366 to €1,397

  • Taxes -€2,749

    down €2,749 (-36.7%), from €7,497 to €4,748

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €17,169
Gross operating margin +€66,762
Staff costs -€73,258
Depreciation +€754
Other operating charges +€2,969
Financial income -€396
Financial charges -€8,549
Taxes +€2,749
Result 2025 €8,200

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€109,213
Investment €0
Financing -€4,000
Cash 2024 €221,962
Net result for the year +€8,200
Depreciation +€4,059
Stocks and contracts -€36,123
Receivables within one year -€83,382
Deferred charges and accrued income -€8,304
Trade debts -€5,096
Tax, wage and social debts +€16,181
Other debts -€4,748
Short-term financial debts -€4,000
Cash 2025 €108,749
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €598,046 €608,583 +€10,537 +1.8%
Fixed assets 21/28 €9,059 €5,001 -€4,059 -44.8%
Tangible fixed assets 22/27 €4,059 €1 -€4,059 -100.0%
Plant, machinery and equipment 23 €4,059 €1 -€4,059 -100.0%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €588,986 €603,583 +€14,596 +2.5%
Stocks and contracts in progress 3 €158,559 €194,683 +€36,123 +22.8%
Stocks 30/36 €158,559 €194,683 +€36,123 +22.8%
Amounts receivable within one year 40/41 €190,228 €273,610 +€83,382 +43.8%
Trade receivables 40 €117,663 €147,998 +€30,335 +25.8%
Other amounts receivable 41 €72,565 €125,612 +€53,047 +73.1%
Cash at bank and in hand 54/58 €221,962 €108,749 -€113,213 -51.0%
Deferred charges and accrued income 490/1 €18,238 €26,541 +€8,304 +45.5%
Total equity and liabilities 10/49 €598,046 €608,583 +€10,537 +1.8%
Equity 10/15 €178,813 €187,013 +€8,200 +4.6%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €5,755 €5,755 = 0.0%
Non-distributable reserves 130/1 €5,755 - -€5,755
Reserves not available under the articles 1311 €5,755 - -€5,755
Distributable reserves 133 - €5,755 +€5,755
Profit (loss) carried forward 14 €148,058 €156,258 +€8,200 +5.5%
Amounts payable 17/49 €419,233 €421,570 +€2,337 +0.6%
Amounts payable within one year 42/48 €419,233 €421,570 +€2,337 +0.6%
Financial debts 43 €254,000 €250,000 -€4,000 -1.6%
Credit institutions 430/8 €254,000 €250,000 -€4,000 -1.6%
Trade debts 44 €146,537 €141,441 -€5,096 -3.5%
Suppliers 440/4 €146,537 €141,441 -€5,096 -3.5%
Taxes, remuneration and social security 45 €13,436 €29,617 +€16,181 +120.4%
Taxes 450/3 €426 €4,071 +€3,645 +856.7%
Remuneration and social security 454/9 €13,011 €25,546 +€12,535 +96.3%
Other amounts payable 47/48 €5,260 €512 -€4,748 -90.3%
Non-recurring operating income 76A €577 - -€577
Remuneration, social security and pensions 62 €130,867 €204,126 +€73,258 +56.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,813 €4,059 -€754 -15.7%
Other operating charges 640/8 €4,366 €1,397 -€2,969 -68.0%
Gross operating margin 9900 €179,178 €245,940 +€66,762 +37.3%
Operating profit (loss) 9901 €39,132 €36,359 -€2,773 -7.1%
Financial income 75/76B €1,798 €1,402 -€396 -22.0%
Recurring financial income 75 €1,798 €1,402 -€396 -22.0%
Financial charges 65/66B €16,264 €24,813 +€8,549 +52.6%
Recurring financial charges 65 €16,264 €24,812 +€8,548 +52.6%
Non-recurring financial charges 66B - €2 +€2
Profit (loss) for the period before taxes 9903 €24,666 €12,948 -€11,718 -47.5%
Income taxes 67/77 €7,497 €4,748 -€2,749 -36.7%
Profit (loss) for the period 9904 €17,169 €8,200 -€8,969 -52.2%
Profit (loss) for the period to be appropriated 9905 €17,169 €8,200 -€8,969 -52.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.